Paul Surdez
Investor Relations Contact presso CATALENT, INC.
Profilo
Paul Surdez is currently the Vice President-Investor Relations at Catalent, Inc. He previously held the same position at Laboratory Corp.
of America Holdings and Labcorp Drug Development, Inc.
Posizioni attive di Paul Surdez
| Società | Posizione | Inizio |
|---|---|---|
| CATALENT, INC. | Investor Relations Contact | 07/01/2020 |
Precedenti posizioni note di Paul Surdez
| Società | Posizione | Fine |
|---|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Investor Relations Contact | - |
| COVANCE INC. | Investor Relations Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| CATALENT, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Paul Surdez
